Robertet (RBTEF) Q2 2026 Earnings Report
RBTEF Q2 2026 EPS Results
- Actual EPS
- $28.92
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- $31.26
RBTEF Q2 2026 Revenue Results
- Actual Revenue
- $497.85M
- Expected Revenue
- $497.85M
- Beat/Miss
- Beat by +$1,120.569
- YoY Revenue Growth
- -0.46%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 09/17/2026
- Time
- During Market Hours
- Conference Call
- Thursday, September 17, 2026
Robertet's next earnings date is estimated for April 21, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
The call was broadly constructive. Robertet delivered positive organic growth, strong Fragrance and Health and Beauty performance, resilient profitability, improved operating cash flow, positive free cash flow, sustainability leadership, and continued investment in future growth. These positives were partly offset by a 0.5% reported revenue decline, weaker Raw Materials and Flavors performance, lower EBITDA versus an exceptionally strong prior-year period, oil-linked cost pressure, a lower-end full-year growth outlook, and currently unsuccessful M&A efforts.
For 2026, Robertet is targeting organic growth of between +3% and +5% for the full-year, with the year to go expected to be between +4.7% and +7%; it expects resilient profitability, with an EBITDA above 21%, and said the second half will be a bit more pricing driven than volume driven, with easier comparatives and a strong baseline. The company is targeting an EBITDA in line with the past three years, while its long-term guidance remains above 20%; CapEx is expected to remain between 4% and 5% of sales. By 2030, Robertet wants to reach between EUR 1.1 billion and EUR 1.2 billion, implying an annual average growth of 5%-7% between 2025 and 2030, including EUR 50 million to EUR 80 million of revenues from targeted acquisitions over this period; its M&A sweet spots are companies between EUR 15 million-EUR 50 million sales, and there is no plan of buyback at the end of the year and in the years to come.
- Positive Organic Growth Despite Currency HeadwindsFirst-half organic growth reached 2.8% despite a moderate market environment, adverse currency effects, and contrasting divisional trends. Reported revenue was EUR 444 million, while currency effects reduced reported growth by 3 percentage points, mainly due to the strengthening euro.
- Strong Fragrance PerformanceThe Fragrance division delivered organic growth of +12.6%, driven especially by niche fine-fragrance brands, emerging players, and strong momentum in Latin America and the East. Management said the trend continued into the second half, with premiumization and rising-star brands supporting performance.
- Health and Beauty Double-Digit GrowthHealth and Beauty delivered organic growth of +11.3%, benefiting from market-expansion initiatives and strengthened scientific and commercial capabilities.
- Strong Growth in Latin America and AsiaLatin America delivered outstanding growth of +21%, supported notably by Brazil and the new creation center in São Paulo. Asia grew by +12%, benefiting from the ramp-up of the Indonesian facility and continued strong momentum in India, particularly in Flavors.
- Resilient ProfitabilityGross profit margin improved by 50 basis points, reflecting a favorable product mix with a strong contribution from Fragrance. Recurring EBITDA reached EUR 94 million, representing a 21.1% margin, which management described as historically strong despite being below the exceptionally high level achieved in H1 2025.
- Positive Net Income and Financial ResultOperating income reached EUR 75 million. Lower financing costs and a less adverse foreign-exchange effect supported the financial result, resulting in group-share net income of EUR 54 million.
- Improved Operating Cash Flow and Positive Free Cash FlowOperating cash flow increased to EUR 40 million from EUR 32 million in H1 2025, mainly benefiting from lower tax payments returning to a more normalized level. Despite EUR 18 million of industrial investment and EUR 6 million of financial investment, free cash flow remained positive at EUR 12.15 million.
- Solid Balance SheetGroup equity reached EUR 647 million at the end of June, and management described the balance sheet as very solid.
- Continued Investment in Future GrowthRobertet continued investing in industrial capacity, scientific and commercial teams, information systems, international footprint, and customer-facing capabilities. Management reiterated a disciplined CapEx framework of between 4% and 5% of sales, including investments in Indonesia, Mexico, Grasse, the U.S., China, Singapore, and other growth regions.
- Sustainability LeadershipRobertet received EcoVadis Platinum recognition for the third consecutive year, improving its score to 89 out of 100 and ranking among the top 1% of companies globally. The group had 67 CSR-verified or certified supply chains as of year-end 2025 and obtained Fair for Life certification for its Rose Damascena supply chain in Bulgaria since January 2026.
- Full-Year Organic Growth TargetManagement is targeting full-year 2026 organic growth of between +3% and +5%. The second-half outlook includes continued strong momentum in Fragrance and in key growth regions, especially Latin America, the Middle East, and Asia.
- Expected EBITDA Margin Above 21% in H2Management expects resilient profitability, with EBITDA above 21% in the second half, supported by pricing actions and disciplined cost management despite continued investment efforts.
- Pricing and Foreign-Exchange ActionsRobertet has taken pricing action to mitigate higher petroleum-derived raw-material costs, particularly in the second half. Management also expects easing foreign-exchange headwinds to favor published turnover and reduce the gap between reported and organic growth.
- Long-Term Growth AmbitionThe Seed to Success 2030 plan remains in place, with a target of EUR 1.1 billion to EUR 1.2 billion of revenue by 2030. This implies annual average growth of 5%-7% between 2025 and 2030, including EUR 50 million to EUR 80 million of revenue from targeted acquisitions.
- Competitive Position in Natural IngredientsManagement said Robertet benefits from its vertically integrated model, leadership in natural ingredients, broad product catalog, supply-chain development, product quality, creativity, and expanding international footprint. The group is also benefiting from premiumization across fine fragrance, personal care, home care, and fabric care.
- New Growth Relays in FlavorsAlthough some beverage categories were softer, management identified dairy, functional food, sports drinks, and savory products as potential growth relays. Robertet created category-manager roles for beverage, dairy, and savory products to support these areas.
- Disciplined M&A ApproachRobertet remains active in screening targeted M&A opportunities, focusing on companies with EUR 15 million-EUR 50 million in sales and avoiding large transformative transactions. Management said the arrival of Matthieu Lugez is expected to dynamize the search through expanded field and financial-partner networks.
- Increasing Dividend Payout PolicyManagement said the company is increasing dividend payouts step-by-step and believes there is room to grow the dividend payout steadily while continuing to prioritize long-term investments.
RBTEF Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Apr 21, 2027 | 2026 (Q4) | ―- | 23.3 | ― | ― |
| Sep 17, 2026 | 2026 (Q2) | ―28.92 | 31.26 | -7.48% (-2.34) | |
| Apr 09, 2026 | 2025 (Q4) | ―23.30 | 20.54 | 13.45% (+2.76) | |
| Sep 11, 2025 | 2025 (Q2) | 31.2631.26 | 27.69 | 12.92% (+3.58) | |
| Apr 14, 2025 | 2024 (Q4) | ―20.54 | 18.59 | 10.44% (+1.94) | |
| Sep 11, 2024 | 2024 (Q2) | ―27.69 | 21.44 | 29.12% (+6.24) | |
| Apr 11, 2024 | 2023 (Q4) | ―18.59 | 15 | 23.96% (+3.59) | |
| Sep 29, 2023 | 2023 (Q2) | ―21.44 | 21.84 | -1.82% (-0.40) | |
| Apr 21, 2023 | 2022 (Q4) | ―15.00 | 16.31 | -8.02% (-1.31) | |
| Sep 30, 2022 | 2022 (Q2) | 19.4021.84 | 18.46 | 18.31% (+3.38) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.